Women experiencing shortages of Hormone Replacement Therapy (HRT) products are encouraged to consult their GP or pharmacist for guidance on alternatives. The Department of Health has confirmed disruptions affecting major brands, including Estradot and FemSeven Conti, due to manufacturing and distribution issues.
Pharmacists emphasize the importance of professional advice to avoid potential side effects from unverified substitutes. Patients are reminded not to share medications and to seek longer-term prescriptions to mitigate future shortages.
Women should proactively discuss longer-term prescriptions with their GPs to navigate ongoing HRT shortages. As alternatives may not be as effective, staying informed about available options and avoiding self-medication is crucial for managing symptoms safely.